Title Handbook of Hematologic Malignancies, 2/e
Subtitle
Author David A. Sallman, Ateefa Chaudhury, Johnny Nguyen, Ling Zhang
ISBN 9780826149763
List price USD 90.00
Price outside India Available on Request
Original price
Binding Paperback
No of pages 500
Book size 127 x 203 mm
Publishing year 2021
Original publisher Demos Medical Publishing
Published in India by .
Exclusive distributors Viva Books Private Limited
Sales territory Bangladesh, India, Pakistan, Sri Lanka
Status New Arrival
About the book Send Enquiry
  
 

Description:

This revised and updated second edition of Handbook of Hematologic Malignancies continues to be an essential and “go-to” resource for the busy hematologist, hematologic oncologist, hematopathologist, oncology advanced practice provider, oncology nurse, and trainee. Concisely organized, each chapter provides the most current, need-to-know points of diagnosis, prognosis, therapeutic management, and clinical trial opportunities for each hematological malignancy. Chapters are complete with richly illustrated figures to highlight the hematopathologic characteristics of diseases in addition to helpful tables on differential diagnosis, prognostic scoring systems, molecular profiles, and therapeutic options. A new case-based chapter concludes the handbook with clinical cases designed to test a clinician’s knowledge of pathologic diagnosis and clinical presentation of diseases covered in the book. With over twenty new FDA-approved indications since publication of the first edition, including breakthroughs with CAR-T therapy, and other evidence-based treatment options for patients with hematologic disease, this book serves as quick reference to practice changing information on challenging diagnostic dilemmas, frontline and refractory treatment scenarios, and more.

The subspecialty field of hematologic oncology is ever-changing and expanding with available treatment options and this second edition keeps the busy clinician abreast of recent findings and their impact on evidence-based treatment and management. Written by experienced clinicians at the world-renowned Moffitt Cancer Center in Tampa, Florida, as well as contributions from leading academicians, hematologists, and oncologists throughout the country, this unique handbook is packed with authoritative knowledge and clinical insight into all known hematologic cancers.

 

Key Features:

  • Includes seven new chapters covering CAR-T and novel therapeutic options including CD19 CAR-T therapy, novel cellular therapies, cytokine release syndrome, cancer associated thrombosis, and more
  • Comprises compact and updated disease-site chapters describing new standards of care and management considerations in bullet point format with key references
  • Highlights important diagnostic tools that assist with conducting key differential diagnoses and unveiling answers to diagnostic dilemmas
  • Provides updates of potential practice-changing clinical trials and paradigm shifting treatment considerations in each disease-based chapter
  • Purchase includes digital access for use on most mobile devices or computers


Contents:

Contributors

Preface

Abbreviations

 

PART I: INTRODUCTION AND OVERVIEW

Chapter 1. Normal Hematopoiesis and Diagnosis Algorithms for Cytopenias and Cytoses (Onyee Chan and Ling Zhang)

Chapter 2. Familial/Inherited Mutations and Risks of Hematologic Malignancies (Sophia C. Korotev, Lucy A. Godley, and Amy M. Trottier)

Chapter 3. Diagnostic Approaches to Hematologic Malignancies (Johnny Nguyen, Rohit Sharma, and Ling Zhang)

Chapter 4. Minimal Residual Disease Assays (Pukhraz Basra and Silvia Tse Bunting)

 

PART II: MYELOPROLIFERATIVE NEOPLASMS

Chapter 5. Polycythemia Vera (Misty Dawn Shields and Kenneth S. Zuckerman)

Chapter 6. Essential Thrombocythemia (Nikesh N. Shah and Kenneth S. Zuckerman)

Chapter 7. Primary Myelofibrosis (Carmelo J. Blanquicett and Andrew Kuykendall)

Chapter 8. Chronic Myelogenous Leukemia (Chetasi Talati, Dasom Caroline Lee, and Javier Pinilla-Ibarz)

Chapter 9. Chronic Neutrophilic Leukemia (Yenny Alejandra Moreno Vanegas, Arun Kadamkulam Syriac, and Utkarsh Acharya)

Chapter 10. Systemic Mastocytosis (Kristen Gonter-Aubin and Andrew Kuykendall)

Chapter 11. PDGFRA/PDGFRB/FGFR1 Myeloid Neoplasms (Joseph Clara and Eric Padron)

 

PART III: MYELODYSPLASTIC AND BONE MARROW FAILURE SYNDROMES

Chapter 12. Myelodysplastic Syndromes (Anthony M. Hunter, David A. Sallman, and Rami Komrokji)

Chapter 13. Aplastic Anemia (Jae Chung and Rami Komrokji)

Chapter 14. Paroxysmal Nocturnal Hemoglobinuria (Hilda Ding)

 

PART IV: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

Chapter 15. Myelodysplastic/Myeloproliferative Overlap Syndromes (Virginia O. Volpe, Jennifer Eatrides and Eric Padron)

Chapter 16. Chronic Myelomonocytic Leukemia (Alexandra Gomez-Arteaga and Justin M. Watts)

 

PART V: ACUTE MYELOID LEUKEMIA AND RELATED SYNDROMES

Chapter 17. Acute Myeloid Leukemia (David M. Swoboda and Kendra Sweet)

Chapter 18. Secondary AML and AML-MRC (Seongseok Yun, David A. Sallman, and Jeffrey E. Lancet)

Chapter 19. Acute Promyelocytic Leukemia (Virginia O. Volpe and Jeffrey E. Lancet)

Chapter 20. Blastic Plasmacytoid Dendritic Cell Neoplasm (Justin Taylor and Andrew A. Lane)

 

PART VI: ACUTE LYMPHOID LEUKEMIA

Chapter 21. B-Lymphoblastic Leukemia/Lymphoma (Fernando Vargas and Bijal Shah)

Chapter 22. BCR-ABL1+ B-Lymphoblastic Leukemia (Yehuda Deutsch and Bijal Shah)

Chapter 23. T-Cell Acute Lymphoblastic Leukemia/Lymphoma (Muhammad Sardar, Ravitharan Krishnadasan, and Keri Maher)

 

PART VII: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE

Chapter 24. Acute Leukemia of Ambiguous Lineage (Muhammad Sardar, Ravitharan Krishnadasan, and Keri Maher)

 

PART VIII: MATURE T- AND NK-CELL LEUKEMIA

Chapter 25. T-Cell Prolymphocytic Leukemia (Pei Zhang and Abhijeet Kumar)

Chapter 26. T-Cell Large Granular Lymphocytic Leukemia (Ning Dong, Magali Van den Bergh, and Lubomir Sokol)

Chapter 27. Aggressive Natural Killer Cell Leukemia (Emilie Wang, Mintallah Haider, and Lubomir Sokol)

 

PART IX: PLASMA CELL DISORDERS

Chapter 28. Monoclonal Gammopathy of Unknown Significance, Smoldering Myeloma, and Plasmacytomas (Hannah Asghari and Brandon Blue)

Chapter 29. Multiple Myeloma (Shonali Midha, Patrick Griffin, and Rachid Baz)

Chapter 30. Waldenström’s Macroglobulinemia (Ariel Grajales-Cruz and Rachid Baz)

Chapter 31. Immunoglobulin Light Chain Amyloidosis (Taxiarchis Kourelis and Morie A. Gertz)

 

PART X: HODGKIN LYMPHOMA

Chapter 32. Hodgkin Lymphoma (Anju Nair)

 

PART XI: NON-HODGKIN LYMPHOMA

Chapter 33. Diagnosis and Classification of Non-Hodgkin Lymphomas (Johnny Nguyen, Haipeng Shao, and Ling Zhang)

 

PART XII: MATURE B-CELL LYMPHOMA

Very Aggressive

Chapter 34. Burkitt Lymphoma (Anju Nair)

 

Aggressive

Chapter 35. Diffuse Large B-Cell Lymphoma (Jose D. Sandoval-Sus and Julio C. Chavez)

Chapter 36. Double-Hit Lymphoma (Nikhil Mukhi)

Chapter 37. Mantle Cell Lymphoma (Ruchi Desai and Bijal Shah)

Chapter 38. Primary Mediastinal Large B-Cell Lymphoma (Vania Phuoc, Andreas Saltos and Julio C. Chavez)

Chapter 39. Primary Central Nervous System Lymphoma (Tony Kurian, Liliana Bustamante, Peter Forsyth, and Solmaz Sahebjam)

Chapter 40. HIV-Related Lymphomas (Danny Nguyen, Nishan Tchekmedyian, and Jeremy S. Abramson)

 

Indolent

Chapter 41. Follicular Lymphoma (Jori Kaplan and Celeste Bello)

Chapter 42. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Emilie Wang, Ateefa Chaudhury, and Javier Pinilla-Ibarz)

Chapter 43. Hairy Cell Leukemia (Justin Taylor and Omar Abdel-Wahab)

Chapter 44. Marginal Zone Lymphoma (Nishan Tchekmedyian, Danny Nguyen, Hayder Saeed, and Celeste Bello)

Chapter 45. Mucosa-Associated Lymphoid Tissue Lymphoma (Nishan Tchekmedyian, Danny Nguyen, and Hayder Saeed)

 

PART XIII: MATURE T-AND NK-CELL LYMPHOMA

Chapter 46. Adult T-Cell Leukemia/Lymphoma (Nikhil Mukhi and Lubomir Sokol)

Chapter 47. Anaplastic Large Cell Lymphoma (Poorvi Desai, Ling Zhang, and Lubomir Sokol)

Chapter 48. Extranodal Natural Killer/T-Cell Lymphoma (Joseph Clara and Lubomir Sokol)

Chapter 49. Mycosis Fungoides (Vania Phuoc and Lubomir Sokol)

Chapter 50. Hepatosplenic T-Cell Lymphoma (Walter Hanel and Narendranath Epperla)

 

PART XIV: HISTIOCYTIC/DENDRITIC CELL NEOPLASMS

Chapter 51. Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Histiocytic Sarcoma (Sameem Abedin and Ehab Atallah)

Chapter 52. Hemophagocytic Lymphohistiocytosis (Hilda Ding and Lubomir Sokol)

 

PART XV: BONE MARROW TRANSPLANTATION

Chapter 53. Autologous Hematopoietic Cell Transplantation (Hemant S. Murthy and Mohamed A. Kharfan-Dabaja)

Chapter 54. Allogeneic Hematopoietic Cell Transplantation (Hemant S. Murthy, Taiga Nishihori and Mohamed A. Kharfan-Dabaja)

 

PART XVI: NEW CELLULAR IMMUNOTHERAPY

Chapter 55. CAR-T Overview and Novel Cellular Therapeutic Options, Including TCR Gene Transfers (Cristian I. Rodriguez Arocho, Marco L. Davila, and David A. Sallman)

Chapter 56. CD19 CAR T-Cell Therapy (Michael D. Jain, Brigett D. Brandjes, and Frederick L. Locke)

Chapter 57. Cytokine Release Syndrome and Other Toxicities Associated With Novel Cellular Therapies (Jennifer M. Logue, Estelle Cervantes, Christina A. Bachmeier, and Marco L. Davila)

 

PART XVII: EMERGENCIES IN HEMATOLOGY

Chapter 58. Cancer-Associated Thrombosis in Hematologic Malignancies (Karen Feghali, Arun Kadamkulam Syriac, and Utkarsh Acharya)

Chapter 59. Tumor Lysis Syndrome (Mintallah Haider and Michael Jaglal)

Chapter 60. Thrombotic Microangiopathy (Jonathan R. Day, Ljiljana V. Vasovic, and Ruchika Goel)

Chapter 61. Therapeutic Apheresis Indications (Ljiljana V. Vasovic, Jonathan R. Day, and Ruchika Goel)

 

PART XVIII: NEW CLINICAL CASES IN MALIGNANT HEMATOLOGY

Chapter 62. Challenging Case Vignettes with Follow-Up Questions

 

Appendix: Pathology Supplement

Index


About the Editor:

David A Sallman, MD is Malignant Oncology Fellow, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, c/o Moffitt Cancer Center and Research Institute, Tampa, FL. “Malignant Oncology Fellow, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, c/o Moffitt Cancer Center and Research Institute, Tampa, FL”Pathology Resident, Department of Pathology, Morsani College of Medicine, University of South Florida, Tampa, FL”Associate Professor, Department of Pathology, Morsani College of Medicine, University of South Florida, c/o Moffitt Cancer Center and Research Institute, Tampa, FL”


Target Audience:

This book is an essential and “go-to” resource for the busy hematologist, hematologic oncologist, hematopathologist, oncology advanced practice provider, oncology nurse, and trainee.

 

 
Special prices are applicable to the authorised sales territory only.
Prices are subject to change without prior notice.